 |
Ricin (blocked) conjugated murine MCA (anti-B4) |
|---|---|
| Trade Name | |
| Orphan Indication | B-cell leukemia and B-cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 1988-11-17 00:00:00 |
| Sponsor | ImmunoGen, Inc.;148 Sidney Street;Cambridge, Massachusetts, 02139 |
